NONSMALL CELL LUNG CANCER
Clinical trials for NONSMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new NONSMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for NONSMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive 'Tumor Seeker' drug enters first human trials for tough cancers
Disease control Recruiting nowThis is a first-in-human study testing a new experimental drug called 212Pb-DOTAM-GRPR1 in adults with advanced cancers that have returned or spread. The main goal is to find a safe and tolerable dose. Researchers will also check if the drug, which delivers radiation directly to …
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Orano Med LLC • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug enters first human trials for Tough-to-Treat lung cancer
Disease control Recruiting nowThis is the first time researchers are testing the experimental drug DZD6008 in people. The study aims to find a safe dose and see if it can shrink tumors in adults with advanced non-small cell lung cancer that has a specific genetic change called an EGFR mutation. The trial will…
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Could standard cancer treatment work for frailer patients?
Disease control Recruiting nowThis study is testing if a standard first-line chemo/immunotherapy treatment for advanced lung cancer works as well and is as safe for patients in poorer health (Performance Status 2) as it is for patients in better health (Performance Status 0-1). It will enroll about 105 adults…
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
New program aims to ease the emotional burden of advanced lung cancer
Symptom relief Recruiting nowThis study is testing a new supportive care program called POISE for people with advanced lung cancer who are receiving targeted therapy. The program involves four visits with a specially trained palliative care clinician to help patients cope with uncertainty, build confidence i…
Matched conditions: NONSMALL CELL LUNG CANCER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Mar 30, 2026 14:35 UTC